Media Pack
News

Current Edition

Volume 16 Issue 2
 
Volume 14 Issue 4

Talking Point with PCI Pharma Services

PCI Pharma Services is a trusted partner for globally integrated CDMO services. Can you tell our readers the brief history of your company, how the company got starte...
12 August 2022 Volume 14 Issue 4
Continue Reading →
Volume 14 Issue 4

The Importance of Conducting Diverse US Trials for US Cancer Patients

Since the early 1990s, overall cancer death rates have declined for most cancers in the US. According to the Annual Report to the Nation on the Status of Cancer – iss...
12 August 2022 Volume 14 Issue 4
Continue Reading →
Volume 14 Issue 4

An Open Letter of Appreciation to Clincial Trial Participants, Patient Advisors, Caregivers and HealthCare Professionals

Thank you! Those of us who have dedicated our careers to medical and health sciences share a mission to improve the lives of people everywhere through the development...
12 August 2022 Volume 14 Issue 4
Continue Reading →
Volume 14 Issue 4

Early Adoption of an Integrated Product Development Strategy will Reap Dividends

With both the cost and time to bring a drug to market ballooning, the importance of an integrated product development (IPD) strategy is gaining traction. This multidi...
12 August 2022 Volume 14 Issue 4
Continue Reading →
Volume 14 Issue 4

Bridging the Gaps in the Analytical Procedure with Bayesian Statistics

The ICH-Q2 has stated that the objective of validation of an analytical procedure is to demonstrate that it is suitable for its intended purpose, yet it – as well as ...
12 August 2022 Volume 14 Issue 4
Continue Reading →
Volume 14 Issue 4

Understanding How Intellectual Property Insurance Can Protect Your Business

Intellectual property is an intangible business asset that often helps set companies apart from their competitors. Unfortunately, few businesses know precisely what t...
12 August 2022 Volume 14 Issue 4
Continue Reading →
Volume 14 Issue 4

Longitudinal Qualitative Research – Capturing the Patient Voice; Enhancing Patient Centricity

One of the best ways to ensure that a sponsor’s clinical and commercial programs reflect how patients experience a disease or a treatment is to interview patients dir...
12 August 2022 Volume 14 Issue 4
Continue Reading →
Volume 14 Issue 4

Clinical Trial Feasibility in a Changing World: Current Trends and Prospects

In recent years, there has been an upsurge in the number of (bio) pharmaceutical products under development globally, reaching an estimated 7,471 products in 2021, wh...
12 August 2022 Volume 14 Issue 4
Continue Reading →
Volume 14 Issue 4

Powerful Techniques Promoting Gene Therapy and Gene-mediated Cell Therapy Progress

Gene therapy and gene-mediated cell therapy (e.g. CAR-T cell therapy) approach hold great promise for treating debilitating diseases with unmet clinical needs. The dr...
12 August 2022 Volume 14 Issue 4
Continue Reading →
Volume 14 Issue 4

Delivering on the Promise of Digital Trials: Simplified Experiences for Sites and Patients

The shift toward decentralised trials (DCTs) was not caused by COVID-19 but has certainly been accelerated by it. Research indicates that just 28% of sponsors and CRO...
12 August 2022 Volume 14 Issue 4
Continue Reading →
 

jcs-white.png

Journal for Clinical Studies

Journal For Clinical Studies has a distinguished editorial advisory board providing the best guidelines for global clinical trials. Your resource for Multisite Studies and emerging markets.

Facebook Linkedin
Journal For Clinical Studies © 2024, All Rights Reserved – Powered by Teksyte